Literature DB >> 21526463

[Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party].

C Gasche1, R Evstatiev, T Haas, A Kaser, P Knoflach, W Petritsch, G Weiss, W Reinisch.   

Abstract

Iron deficiency with and without anaemia is a common burden of patients with inflammatory bowel diseases (IBD) and has considerable impact on their quality of life and the ability to perform. The IBD working group of the Austrian Society of Gastroenterology and Hepatology developed five consensus statements on the following topics: (i) diagnosis of iron deficiency and (ii) anaemia, (iii) screening of iron deficiency, (iv) treatment of iron deficiency and (v) therapeutic goals. The clinical importance of intravenous iron replacement therapy in IBD with regard to effectiveness and compliance was discussed. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21526463     DOI: 10.1055/s-0031-1273324

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  8 in total

1.  High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life.

Authors:  Santiago García-López; Judith Millastre Bocos; Javier P Gisbert; Eduardo Bajador; María Chaparro; Carlos Castaño; José A García-Erce; Fernando Gomollón
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

2.  Anaemia in the Elderly IBD Patient.

Authors:  Jürgen Stein; Axel U Dignass
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 3.  Anemia in inflammatory bowel disease: a neglected issue with relevant effects.

Authors:  Danila Guagnozzi; Alfredo J Lucendo
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.

Authors:  Stefanie Kulnigg-Dabsch; Rayko Evstatiev; Clemens Dejaco; Christoph Gasche
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

5.  High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort.

Authors:  Claudia Ott; Anne Liebold; Angela Takses; Ulrike G Strauch; Florian Obermeier
Journal:  Gastroenterol Res Pract       Date:  2012-07-30       Impact factor: 2.260

6.  Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.

Authors:  Jorge E Toblli; Gabriel Cao; Margarita Angerosa
Journal:  Drug Des Devel Ther       Date:  2015-05-07       Impact factor: 4.162

Review 7.  Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis.

Authors:  Zoe Tolkien; Lynne Stecher; Adrian P Mander; Dora I A Pereira; Jonathan J Powell
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

8.  Iron Deficiency Is Common During Remission in Children With Inflammatory Bowel Disease.

Authors:  Emma Wikholm; Petter Malmborg; Maria Forssberg; Carl-Axel Hederos; Sverre Wikström
Journal:  Glob Pediatr Health       Date:  2016-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.